Bristol-Myers Squibb Company is mobilising researchers at 10 different institutes in the US and Europe to investigate the role of immunotherapies in treating cancer. The project has been launched under the name ‘immuno-oncology network’. ---Subscribe to MedNous to access this article--- Research & University News Company News
